0001209191-22-023090.txt : 20220405
0001209191-22-023090.hdr.sgml : 20220405
20220405164921
ACCESSION NUMBER: 0001209191-22-023090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220401
FILED AS OF DATE: 20220405
DATE AS OF CHANGE: 20220405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leneghan Kathleen P.
CENTRAL INDEX KEY: 0001722868
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 22807745
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
CITY: ELYRIA
STATE: OH
ZIP: 44035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-01
0
0000742112
INVACARE CORP
IVC
0001722868
Leneghan Kathleen P.
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Senior VP and CFO
Common Shares
2022-04-01
4
A
0
74734
0.00
A
241501
D
Common Shares
4976
I
By Invacare Retirement Savings Plan
Employee Stock Option (Right to Buy)
Common Shares
16000
16000
D
Phantom Stock
Common Shares
363
363
D
Restricted shares granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2023.
Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2021, the most recent information reasonably available.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5.
The reporting person holds previously reported options to buy 16,000 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 14, 2012 and March 18, 2013, at exercise prices between $13.37 to $14.49 per share, will expire between August 14, 2022 and March 18, 2023, and became exercisable between September 30, 2013 and March 31, 2017.
Upon cessation of employment in accordance with the terms and conditions of the Invacare Corporation Deferred Compensation Plus Plan.
Owned by Trustee for the Invacare Corporation Deferred Compensation Plus Plan. The information given is based on a Plan Statement of December 31, 2021, the most recent information reasonably available.
/s/ Kathleen P. Leneghan, by Kristofer K. Spreen, her attorney-in-fact, pursuant to Power of Attorney dated November 10, 2017, on file with the Commission
2022-04-05